A	O
lipodystrophy	O
-	O
causing	O
lamin	O
A	O
mutant	O
alters	O
conformation	O
and	O
epigenetic	O
regulation	O
of	O
the	O
anti	O
-	O
adipogenic	O
MIR335	O
locus	O
.	O


Mutations	O
in	O
the	O
Lamin	O
A	O
/	O
C	O
(	O
LMNA	O
)	O
gene	O
-	O
encoding	O
nuclear	O
LMNA	O
cause	O
laminopathies	O
,	O
which	O
include	O
partial	O
lipodystrophies	O
associated	O
with	O
metabolic	O
syndromes	O
.	O


The	O
lipodystrophy	O
-	O
associated	O
LMNA	O
p	O
.	O
R482W	O
mutation	O
is	O
known	O
to	O
impair	O
adipogenic	O
differentiation	O
,	O
but	O
the	O
mechanisms	O
involved	O
are	O
unclear	O
.	O


We	O
show	O
in	O
this	O
study	O
that	O
the	O
lamin	O
A	O
p	O
.	O
R482W	O
hot	O
spot	O
mutation	O
prevents	O
adipogenic	O
gene	O
expression	O
by	O
epigenetically	O
deregulating	O
long	B-ENHANCER
-	I-ENHANCER
range	I-ENHANCER
enhancers	I-ENHANCER
of	I-ENHANCER
the	I-ENHANCER
anti	I-ENHANCER
-	I-ENHANCER
adipogenic	I-ENHANCER
MIR335	I-ENHANCER
microRNA	I-ENHANCER
gene	E-ENHANCER
in	O
human	O
adipocyte	O
progenitor	O
cells	O
.	O


The	O
R482W	O
mutation	O
results	O
in	O
a	O
loss	O
of	O
function	O
of	O
differentiation	O
-	O
dependent	O
lamin	O
A	O
binding	O
to	O
the	O
MIR335	O
locus	O
.	O


This	O
impairs	O
H3K27	O
methylation	O
and	O
instead	O
favors	O
H3K27	O
acetylation	O
on	O
MIR335	B-ENHANCER
enhancers	E-ENHANCER
.	O


The	O
lamin	O
A	O
mutation	O
further	O
promotes	O
spatial	O
clustering	O
of	O
MIR335	B-ENHANCER
enhancer	E-ENHANCER
and	O
promoter	O
elements	O
along	O
with	O
overexpression	O
of	O
the	O
MIR355	O
gene	O
after	O
adipogenic	O
induction	O
.	O


Our	O
results	O
link	O
a	O
laminopathy	O
-	O
causing	O
lamin	O
A	O
mutation	O
to	O
an	O
unsuspected	O
deregulation	O
of	O
chromatin	O
states	O
and	O
spatial	O
conformation	O
of	O
an	O
miRNA	O
locus	O
critical	O
for	O
adipose	O
progenitor	O
cell	O
fate	O
.	O
